SCHEMBL3840650

SCHEMBL3840650

C=C(C)C(=O)OC1C2CC3CC(C2)CC1C3.Oc1ccc(C=CC=Cc2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.37
HSD11B1 P28845 4/20 0.36
CYP3A4 P08684 3/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
APP P05067 1/20 0.36
STAT3 P40763 1/20 0.35
HSPD1 P10809 2/20 0.35
HSPE1 P61604 2/20 0.35
KMT2A Q03164 2/20 0.35
PKM P14618 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH2 P05091 1/20 0.35
MAPT P10636 1/20 0.35
CYP19A1 P11511 1/20 0.35
F3 P13726 1/20 0.35
MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453756 0.91 MAPT (0.39) ESR1APPSTAT3RAB9AMAPT
SCHEMBL5443923 0.90 MMP1 (0.37) ESR1STAT3RELAMAOAMAOB
SCHEMBL5439241 0.88 CA12 (0.36) ESR1APPSTAT3RAB9AMAPT
SCHEMBL5436790 0.88 CYP1A2 (0.36) ESR1APPSTAT3KMT2ARAB9A
SCHEMBL5441675 0.88 ESR1 (0.38) ESR1APPSTAT3KMT2ARAB9A
SCHEMBL5454866 0.86 ESR1 (0.37) ESR1RAB9AMAPTCA12CA7
SCHEMBL3842870 0.86 STAT3 (0.37) ESR1APPSTAT3KMT2ARAB9A
SCHEMBL5446186 0.85 SMN1; SMN2 (0.39) ESR1STAT3KMT2ANFKB1RAB9A
4-Vinylphenol SCHEMBL3842785 0.84 ESR1 (0.36) ESR1HSD11B1KMT2AMEN1MAPT
SCHEMBL5446382 0.84 ESR1 (0.36) ESR1STAT3CA12AKR1B10AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1669462-B1 METHOD OF PREPARING ALPHA-GLYCOSYLISOQUERCITRIN, INTERMEDIATE THEREFOR AND BY-PRODUCT SAN EI GEN FFI INC (JP) 2009-11-11 EP claimed
EP-1669462-B1 METHOD OF PREPARING ALPHA-GLYCOSYLISOQUERCITRIN, INTERMEDIATE THEREFOR AND BY-PRODUCT SAN EI GEN FFI INC (JP) 2009-11-11 EP disclosed
EP-1449833-B1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION WAKO PURE CHEM IND LTD (JP) 2009-09-09 EP disclosed
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-7312014-B2 Poly(p-hydroxystyrene/styrene/alkyl acrylate) terpolymer derivative and acid generator comprising triphenylsulfonium benzenesulfonate derivative; forming positive pattern using transcription technology in high vacuum with irradiated energy such as electron beam, extreme ultraviolet ray and X-ray WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2007-12-25 US disclosed
US-6949329-B2 Pattern formation method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-09-27 US disclosed
WO-2005030975-A1 METHOD OF PREPARING α-GLYCOSYLISOQUERCITRIN, INTERMEDIATE THEREFOR, AND BY-PRODUCT SAN-EI GEN F.F.I., INC. (JP) 2005-04-07 WO disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
US-20040170918-A1 Poly(p-hydroxystyrene/styrene/alkyl acrylate) terpolymer derivative and acid generator comprising triphenylsulfonium benzenesulfonate derivative; forming positive pattern using transcription technology in high vacuum with irradiated energy such as electron beam, extreme ultraviolet ray and X-ray WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2004-09-02 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed
EP-1113005-B1 Sulfonium salt compounds WAKO PURE CHEM IND LTD (JP) 2003-08-06 EP disclosed
US-20030017425-A1 Pattern formation method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2003-01-23 US disclosed
EP-1238969-A2 Sulfonium salt compounds Wako Pure Chemical Industries, Ltd. (JP) 2002-09-11 EP disclosed
EP-1113005-A1 Sulfonium salt compounds Wako Pure Chemical Industries, Ltd. (JP) 2001-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 ESR1 2503/4885HSD11B1 2758/4885CYP3A4 2399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.